Barings’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.07M | Sell |
1,162
-703
| -38% | -$713K | 0.02% | 136 |
|
|
2025
Q4 | $2M | Buy |
1,865
+1,297
| +228% | +$1.24M | 0.04% | 110 |
|
|
2025
Q3 | $433K | Sell |
568
-678
| -54% | -$505K | 0.01% | 148 |
|
|
2025
Q2 | $971K | Buy |
1,246
+55
| +5% | +$42.7K | 0.02% | 133 |
|
|
2025
Q1 | $984K | Sell |
1,191
-478
| -29% | -$398K | 0.02% | 131 |
|
|
2024
Q4 | $1.29M | Buy |
1,669
+1,194
| +251% | +$989K | 0.03% | 121 |
|
|
2024
Q3 | $421K | Sell |
475
-7
| -1% | -$6.29K | 0.01% | 142 |
|
|
2024
Q2 | $436K | Buy |
+482
| New | +$386K | 0.01% | 133 |
|
|
2024
Q1 | – | Sell |
-561
| Closed | -$327K | – | 163 |
|
|
2023
Q4 | $327K | Hold |
561
| – | – | 0.01% | 133 |
|
|
2023
Q3 | $301K | Sell |
561
-21
| -4% | -$10.8K | 0.01% | 132 |
|
|
2023
Q2 | $273K | Buy |
+582
| New | +$244K | 0.01% | 149 |
|
|
2023
Q1 | – | Sell |
-1,889
| Closed | -$691K | – | 179 |
|
|
2022
Q4 | $691K | Sell |
1,889
-474
| -20% | -$168K | 0.02% | 132 |
|
|
2022
Q3 | $764K | Sell |
2,363
-2,171
| -48% | -$688K | 0.03% | 128 |
|
|
2022
Q2 | $1.47M | Buy |
4,534
+1,929
| +74% | +$579K | 0.05% | 139 |
|
|
2022
Q1 | $746K | Sell |
2,605
-109
| -4% | -$28.1K | 0.02% | 186 |
|
|
2021
Q4 | $749K | Sell |
2,714
-65
| -2% | -$16.5K | 0.02% | 210 |
|
|
2021
Q3 | $642K | Sell |
2,779
-1,748
| -39% | -$431K | 0.01% | 219 |
|
|
2021
Q2 | $1.04M | Sell |
4,527
-537
| -11% | -$108K | 0.02% | 209 |
|
|
2021
Q1 | $946K | Sell |
5,064
-647
| -11% | -$127K | 0.02% | 238 |
|
|
2020
Q4 | $964K | Sell |
5,711
-52,445
| -90% | -$7.83M | 0.02% | 231 |
|
|
2020
Q3 | $8.61M | Sell |
58,156
-13,912
| -19% | -$2.15M | 0.2% | 87 |
|
|
2020
Q2 | $10M | Hold |
72,068
| – | – | 0.33% | 58 |
|
|
2020
Q1 | $10M | Sell |
72,068
-5,411
| -7% | -$743K | 0.33% | 58 |
|
|
2019
Q4 | $10.2M | Buy |
77,479
+17,512
| +29% | +$2.03M | 0.27% | 67 |
|
|
2019
Q3 | $6.71M | Buy |
59,967
+1,620
| +3% | +$180K | 0.15% | 130 |
|
|
2019
Q2 | $6.46M | Buy |
58,347
+12,860
| +28% | +$1.51M | 0.14% | 140 |
|
|
2019
Q1 | $5.9M | Sell |
45,487
-37,853
| -45% | -$4.6M | 0.14% | 126 |
|
|
2018
Q4 | $9.64M | Sell |
83,340
-4,971
| -6% | -$555K | 0.17% | 96 |
|
|
2018
Q3 | $9.48M | Sell |
88,311
-11,548
| -12% | -$1.15M | 0.13% | 120 |
|
|
2018
Q2 | $8.52M | Buy |
99,859
+13,940
| +16% | +$1.14M | 0.12% | 128 |
|
|
2018
Q1 | $6.65M | Sell |
85,919
-154
| -0.2% | -$12.4K | 0.1% | 154 |
|
|
2017
Q4 | $7.27M | Buy |
86,073
+40,252
| +88% | +$3.42M | 0.09% | 157 |
|
|
2017
Q3 | $3.92M | Buy |
45,821
+22,400
| +96% | +$1.84M | 0.07% | 176 |
|
|
2017
Q2 | $1.93M | Sell |
23,421
-3,821
| -14% | -$312K | 0.06% | 317 |
|
|
2017
Q1 | $2.29M | Buy |
27,242
+13,621
| +100% | +$1.09M | 0.03% | 554 |
|
|
2016
Q4 | $1M | Hold |
13,621
| – | – | 0.03% | 459 |
|
|
2016
Q3 | $1.09M | Hold |
13,621
| – | – | 0.03% | 419 |
|
|
2016
Q2 | $1.07M | Sell |
13,621
-29,200
| -68% | -$2.2M | 0.03% | 466 |
|
|
2016
Q1 | $3.08M | Sell |
42,821
-33,500
| -44% | -$2.53M | 0.08% | 181 |
|
|
2015
Q4 | $6.43M | Sell |
76,321
-1,200
| -2% | -$99.6K | 0.16% | 73 |
|
|
2015
Q3 | $6.49M | Buy |
77,521
+52,900
| +215% | +$4.47M | 0.16% | 74 |
|
|
2015
Q2 | $2.06M | Sell |
24,621
-32,711
| -57% | -$2.49M | 0.06% | 314 |
|
|
2015
Q1 | $4.17M | Sell |
57,332
-10,400
| -15% | -$740K | 0.1% | 156 |
|
|
2014
Q4 | $4.67M | Buy |
67,732
+19,500
| +40% | +$1.32M | 0.1% | 149 |
|
|
2014
Q3 | $3.13M | Buy |
48,232
+31,400
| +187% | +$1.99M | 0.07% | 214 |
|
|
2014
Q2 | $1.05M | Sell |
16,832
-39,820
| -70% | -$2.38M | 0.03% | 482 |
|
|
2014
Q1 | $3.33M | Sell |
56,652
-24,100
| -30% | -$1.34M | 0.1% | 186 |
|
|
2013
Q4 | $4.12M | Sell |
80,752
-43,200
| -35% | -$2.16M | 0.17% | 135 |
|
|
2013
Q3 | $6.24M | Sell |
123,952
-21,300
| -15% | -$1.12M | 0.27% | 82 |
|
|
2013
Q2 | $7.13M | Buy |
+145,252
| New | +$7.9M | 0.32% | 66 |
|
Other funds holding LLY
VCM
VPM
Barings's LLY Position: Q1 2026 in Review
Barings reduced its Eli Lilly (LLY) stake by 38% in Q1 2026, selling an estimated $713K and leaving 1,162 shares worth $1.07M. The position accounts for 0.02% of the portfolio, ranked #136.
Barings first reported a position in LLY in Q2 2013 and has held it in 50 quarters since. The position peaked at $10.2M in Q4 2019. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Barings held 1,162 shares of Eli Lilly worth $1.07M as of Q1 2026.
- Barings sold 703 Eli Lilly shares in Q1 2026, an estimated $713K.
- Eli Lilly made up 0.02% of Barings's portfolio in Q1 2026, its #136 holding.
- Barings first reported a position in Eli Lilly in Q2 2013 and has held it in 50 quarters since.
- Barings's Eli Lilly position peaked at $10.2M in Q4 2019.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Barings's 13F filing for Q1 2026, filed 6 May 2026.